We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Pharmaceutical Sciences and Drug Design

2021 Volume 1

In Vitro Stability Assessment of Ketoprofen Tablets Under ICHQ1A Guideline


, , ,
  1. Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania.
Abstract

One of the critical components of the pharmaceutical industry is the capacity of pharmaceutical forms to remain stable over time and maintain their quality under different storage and transportation circumstances. Therefore, the amount of active components in the pharmaceutical form is evaluated following the ICHQ1A standards of the European Pharmacopoeia to ascertain the validity of the pharmaceutical product. This paper aims to investigate the stability of 100 mg ketoprofen tablets. Short-term stability experiments were conducted under accelerated conditions (6 months) at 40 ± 2 °C and 75 ± 5% relative humidity, while long-term stability studies (36 months) were conducted at 25 ± 2 °C and 60 ± 5% relative humidity. Using high-performance liquid chromatography, the amount of ketoprofen released from the 100 mg ketoprofen pills was ascertained. These investigations showed that 100 mg ketoprofen tablets have a shelf life of three years and after 36 months, the ketoprofen content of the tablets was more than 95%.


How to cite this article
Vancouver
Ganea M, (Groza) FM, Vicaș LG, Moisa CF. In Vitro Stability Assessment of Ketoprofen Tablets Under ICHQ1A Guideline. Pharm Sci Drug Des. 2021;1:41-6. https://doi.org/10.51847/tpXb5Q0oD1
APA
Ganea, M., (Groza), F. M., Vicaș, L. G., & Moisa, C. F. (2021). In Vitro Stability Assessment of Ketoprofen Tablets Under ICHQ1A Guideline. Pharmaceutical Sciences and Drug Design, 1, 41-46. https://doi.org/10.51847/tpXb5Q0oD1

About GalaxyPub

Find out more

Galaxy Publication is an independent scholarly publishing platform operating under the scientific and organizational designation of Eshragh Scientific and Research Center and the legal framework of ISRAK PUBLISHER EGITIM HIZMETLERI LIMITED.

The publisher is committed to ethical, transparent, and high-quality academic publishing and supports scholarly communication through internationally aligned editorial practices, publication ethics, and responsible dissemination of scientific research.